FDA approves glecaprevir-pibrentasvir for HCV
admin 15th August 2017 Uncategorised 0American Pharmacists Association News More: FDA approves glecaprevir-pibrentasvir for HCV Source: MDlinx
read more
American Pharmacists Association News More: FDA approves glecaprevir-pibrentasvir for HCV Source: MDlinx
read moreAmerican Pharmacists Association News More: FDA to expand public education campaign to focus on prevention of youth e-cigarette use Source: MDlinx
read moreWord is tech giant and retail category-killer Amazon might jump into the drug business. While the company itself hasn’t revealed any plans, a new Goldman Sachs report details just how the company might look to shake things up for pharma,
read moreMerck & Co. CEO Ken Frazier has resigned from President Trump’s manufacturing council, issuing an indirect criticism of the president for not taking a stronger stand about the actions of white supremacists in which an opposing protester was killed over
read moreFosun Pharma and Shanghai Pharma, the two Chinese companies previously rumored to be eyeing generics maker Stada, are back on the M&A radar. And rather than publicly denying their deal interest this time, the two have confirmed offers for U.S. drugmaker
read moreNearly one year ago, as the pharma industry was beset by pricing scrutiny, Allergan CEO Brent Saunders pledged to keep his company’s hikes under 10%. Since then, that pricing rule has spread—even among companies that haven’t publicly promised to do the
read more© 1994 - 2026 B.M. Pharmaceuticals